Forward Equity Partners
Global Healthcare Private Equity Firm
About us
Cross-border private equity firm focused on Healthcare / Life Science investments globally
Formerly Medivate Partners, Forward Equity Partners is a leading PE firm in Korea with proven track record in cross-border/healthcare transactions
What we do
We invest in innovative companies that provide essential technology and infrastructure for human health advancement
PEOPLE
Proven industry veterans
CEO & Managing PaRtner
Paul H. Kim
Advisory Partner
Alain Schreiber
ManAging partner
Hong Jun Park
Venture Partner
Alain Rolland
Media Center
Matica Bio Aims to Surpass China’s Wuxi and Dominate the Global Cell & Gene Therapy CDMO Market
Sep 2025
Matica Bio’s ‘Paul Kim Effect’: Partnerships with Innovative Companies Validate Viral Vector Platform Technology
Sep 2025
CHA Biotech’s Matica Biotechnology Expands Global CGT CDMO Network, Driving Revenue Growth
Jun 2024
CHA Biotech’s U.S. Subsidiary Matica Biotechnology Appoints Paul Kim as CEO
Feb 2024
Numbers
Our growing figures
Current Investments
Exits in healthcare
0
COGNATE BIOSERVICES
Feb 2021, Acquired by Charles River Laboratories
GENOPIS, Inc.
Mar 2021, Acquired by Wacker Chemie AG
WCCT GLOBAL
Feb 2021, Acquired by Altasciences/Novo Holdings
SILLAJEN
Dec 2017, Exited in public market